At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GRI GRI BIO INC
Not Yet Opened 01-06 16:00:00 EST
0.8320
-0.0750
-8.27%
盘后0.8509
+0.0189+2.27%
19:39 EST
High0.9100
Low0.8006
Vol263.72K
Open0.9100
D1 Closing0.9070
Amplitude12.06%
Mkt Cap7.43M
Tradable Cap7.42M
Total Shares8.93M
T/O227.04K
T/O Rate2.96%
Tradable Shares8.92M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Wesco 2024 Sustainability Report: Culture of Compliance
GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that develops as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in La Jolla, California.